Citazione APA

Kameshima, H., Tsuruma, T., Kutomi, G., Shima, H., Iwayama, Y., Kimura, Y., . . . Hirata, K. (2012). Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2B‐derived peptide vaccination for advanced pancreatic cancer patients. Cancer Sci.

Stile di citazione Chicago

Kameshima, Hidekazu, et al. "Immunotherapeutic Benefit of α‐interferon (IFNα) in Survivin2B‐derived Peptide Vaccination for Advanced Pancreatic Cancer Patients." Cancer Sci 2012.

Citazione MLA

Kameshima, Hidekazu, et al. "Immunotherapeutic Benefit of α‐interferon (IFNα) in Survivin2B‐derived Peptide Vaccination for Advanced Pancreatic Cancer Patients." Cancer Sci 2012.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.